MycoMedica
MycoMedica Life Sciences, PBC is a clinical-stage biopharmaceutical company founded by mycologist Paul Stamets and backed by Obvious Ventures, True Ventures, and Kittyhawk Ventures. The company develops fungi-derived therapeutic drugs, including its lead psilocybin candidate MLS101 and the "Stamets Stack" (a novel blend of niacin, psilocybin, and lion's mane), for the prevention and treatment of psychiatric and neurological disorders. It raised $60 million in Series A funding in 2022 and is advancing pre-clinical and clinical research toward FDA approval. MycoMedica is a life-sciences drug-development company and publishes no public developer API, documentation, or developer portal.
MycoMedica is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Life Sciences, Drug Development, and Psychedelics.
Kin Score
Resources
Company 1
The organization behind the API